Derisk & Explore with the Comprehensive Power of Caris Life Sciences’ Assure Liquid Biopsy Platform
Time: 12:00 pm
day: Day One AM
Details:
- Integrated molecular profiling platform designed to accelerate and de-risk biopharma therapeutic development while enhancing the precision and reliability of clinical trials
- Critical analysis of buffy coat to provide precise insights into clonal hematopoiesis (CH) and the impact of germline mutations on therapeutic response and patient stratification
- Expanding the range of Assure solutions spanning the entire cancer continuum, enabling advanced molecular insights
